Mendelian randomization study of height and risk of colorectal cancer
- PMID: 25997436
- PMCID: PMC4481609
- DOI: 10.1093/ije/dyv082
Mendelian randomization study of height and risk of colorectal cancer
Abstract
Background: For men and women, taller height is associated with increased risk of all cancers combined. For colorectal cancer (CRC), it is unclear whether the differential association of height by sex is real or is due to confounding or bias inherent in observational studies. We performed a Mendelian randomization study to examine the association between height and CRC risk.
Methods: To minimize confounding and bias, we derived a weighted genetic risk score predicting height (using 696 genetic variants associated with height) in 10,226 CRC cases and 10,286 controls. Logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (95% CI) for associations between height, genetically predicted height and CRC.
Results: Using conventional methods, increased height (per 10-cm increment) was associated with increased CRC risk (OR = 1.08, 95% CI = 1.02-1.15). In sex-specific analyses, height was associated with CRC risk for women (OR = 1.15, 95% CI = 1.05-1.26), but not men (OR = 0.98, 95% CI = 0.92-1.05). Consistent with these results, carrying greater numbers of (weighted) height-increasing alleles (per 1-unit increase) was associated with higher CRC risk for women and men combined (OR = 1.07, 95% CI = 1.01-1.14) and for women (OR = 1.09, 95% CI = .01-1.19). There was weaker evidence of an association for men (OR = 1.05, 95% CI = 0.96-1.15).
Conclusion: We provide evidence for a causal association between height and CRC for women. The CRC-height association for men remains unclear and warrants further investigation in other large studies.
Keywords: Body height; colorectal cancer; epidemiology.
© The Author 2015; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
Figures
Similar articles
-
Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.PLoS Med. 2016 Sep 6;13(9):e1002118. doi: 10.1371/journal.pmed.1002118. eCollection 2016 Sep. PLoS Med. 2016. PMID: 27598322 Free PMC article.
-
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses.BMC Med. 2020 Sep 3;18(1):229. doi: 10.1186/s12916-020-01703-w. BMC Med. 2020. PMID: 32878631 Free PMC article.
-
The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.Cancer Causes Control. 2015 Nov;26(11):1603-16. doi: 10.1007/s10552-015-0654-9. Epub 2015 Sep 19. Cancer Causes Control. 2015. PMID: 26387087 Free PMC article.
-
Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk.Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1024-31. doi: 10.1158/1055-9965.EPI-14-1309. Epub 2015 May 14. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25976416 Free PMC article.
-
Height and risk of colorectal cancer: a meta-analysis.Eur J Cancer Prev. 2018 Nov;27(6):521-529. doi: 10.1097/CEJ.0000000000000390. Eur J Cancer Prev. 2018. PMID: 28683006 Review.
Cited by
-
Genetically Determined Height and Risk of Non-hodgkin Lymphoma.Front Oncol. 2020 Jan 28;9:1539. doi: 10.3389/fonc.2019.01539. eCollection 2019. Front Oncol. 2020. PMID: 32064237 Free PMC article.
-
Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.PLoS Med. 2016 Sep 6;13(9):e1002118. doi: 10.1371/journal.pmed.1002118. eCollection 2016 Sep. PLoS Med. 2016. PMID: 27598322 Free PMC article.
-
Genomic insights into growth and its disorders: an update.Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):51-6. doi: 10.1097/MED.0000000000000209. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 26702851 Free PMC article. Review.
-
Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals' Risk Profiles.J Natl Cancer Inst. 2021 Sep 4;113(9):1177-1185. doi: 10.1093/jnci/djab041. J Natl Cancer Inst. 2021. PMID: 33734405 Free PMC article.
-
Association Between Height and Clinical Outcome in Metastatic Colorectal Cancer Patients Enrolled Onto a Randomized Phase 3 Clinical Trial: Data From the FIRE-3 Study.Clin Colorectal Cancer. 2018 Sep;17(3):215-222.e3. doi: 10.1016/j.clcc.2018.05.003. Epub 2018 May 10. Clin Colorectal Cancer. 2018. PMID: 29880436 Free PMC article. Clinical Trial.
References
-
- World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cnacer: A Global Perspective . Washington, DC: Cancer Research Fund/American Institute for Cancer Research, 2007.
-
- Hughes LA, Simons CC, van den Brandt PA, Goldbohm RA, van Engeland M, Weijenberg MP. Body size and colorectal cancer risk after 16.3 years of follow-up: an analysis from the Netherlands Cohort Study. Am J Epidemiol 2011;174:1127–39. - PubMed
-
- Campbell PT, Cotterchio M, Dicks E, Parfrey P, Gallinger S, McLaughlin JR. Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2007;16:1735–44. - PubMed
-
- Bowers K, Albanes D, Limburg P, et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol 2006;164:652–64. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 CA059045/CA/NCI NIH HHS/United States
- P01 CA 087969/CA/NCI NIH HHS/United States
- HHSN271201100004C/PHS HHS/United States
- HHSN268201100001C/PHS HHS/United States
- R01 CA076366/CA/NCI NIH HHS/United States
- U24 CA074783/CA/NCI NIH HHS/United States
- P50 CA 127003/CA/NCI NIH HHS/United States
- U01CA137088/CA/NCI NIH HHS/United States
- R01 137178/PHS HHS/United States
- R25 CA094880/CA/NCI NIH HHS/United States
- R01 CA151993/CA/NCI NIH HHS/United States
- U01 CA137088/CA/NCI NIH HHS/United States
- U24 CA074794/CA/NCI NIH HHS/United States
- RFA # CA-95-011/CA/NCI NIH HHS/United States
- U01 CA164930/CA/NCI NIH HHS/United States
- R01 CA 151993/CA/NCI NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- HHSN268201100003C/PHS HHS/United States
- U24 CA097735/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- NIH GEI U01 HG 004438/HG/NHGRI NIH HHS/United States
- HHSN268201100004C/PHS HHS/United States
- Intramural NIH HHS/United States
- R01CA137178/CA/NCI NIH HHS/United States
- R01 CA48998/CA/NCI NIH HHS/United States
- Canadian Institutes of Health Research/Canada
- U01 CA122839/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- NIH U01 HG004446/HG/NHGRI NIH HHS/United States
- U01 CA097735/CA/NCI NIH HHS/United States
- R01 CA042182/CA/NCI NIH HHS/United States
- UM1 CA167551/CA/NCI NIH HHS/United States
- HHSN268201100046C/PHS HHS/United States
- S10 OD020069/OD/NIH HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- P01CA 055075/CA/NCI NIH HHS/United States
- Z01 CP 010200/CP/NCI NIH HHS/United States
- HHSN268201100002C/PHS HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
